Superoxide dismutase 3 (SOD3), an antioxidant enzyme, is highly expressed in lung cancer and is associated with worse survival outcomes, suggesting the exploration of the role of SOD3 in chemotherapy resistance (Saxena et al., 2022; Zhang et al., 2022). This evidence concerns the gene SOD3 and lung carcinoma.